Drug intelligence / Profile preview

PI 82

Development stage
Unknown
Lead developer
UPSA
Modality
Small Molecules, Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

PI 82 is a standardized, non-hormonal, purified extract derived from the pollen and pistils of specific grasses, including rye (*Secale cereale*), orchard grass (*Dactylis glomerata*), and Scots pine (*Pinus silvestris*). Primarily used to alleviate vasomotor symptoms of menopause, such as hot flashes and night sweats, as well as symptoms of premenstrual syndrome (PMS), it serves as a non-estrogenic alternative to hormone replacement therapy. Its mechanism of action is thought to involve the modulation of the serotonergic system in the central nervous system, specifically by inhibiting serotonin reuptake, which helps regulate thermoregulation, mood, and sleep. Additionally, PI 82 contains superoxide dismutase (SOD) mimics, including flavonoids and polyphenols, which contribute antioxidant and anti-inflammatory properties. The extraction process removes the pollen shells and allergens, making it suitable for individuals with pollen allergies.

Brand names
RelizenFemalSerelysFemelis Meno
Other names
Purified Swedish pollen extractPollen and pistil extractStandardized pollen extract
02

Targets

SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on PI 82.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PI 82.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call